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PCardiac Imaging
Computed Tomographic Angiography
Characteristics of Atherosclerotic Plaques
Subsequently Resulting in Acute Coronary Syndrome
Sadako Motoyama, MD, PHD,*‡ Masayoshi Sarai, MD, PHD,* Hiroto Harigaya, MD,*
Hirofumi Anno, MD, PHD,† Kaori Inoue, MD,* Tomonori Hara, MD,* Hiroyuki Naruse, MD, PHD,*
Junichi Ishii, MD, PHD,* Hitoshi Hishida, MD, PHD,* Nathan D. Wong, PHD,‡ Renu Virmani, MD,§
Takeshi Kondo, MD, PHD, Yukio Ozaki, MD, PHD,* Jagat Narula, MD, PHD‡
Toyoake and Takasaki, Japan; Irvine, California; and Gaithersburg, Maryland
Objectives In a computed tomographic (CT) angiography study, we identified the characteristics of atherosclerotic lesions
that were associated with subsequent development of acute coronary syndrome (ACS).
Background The CT characteristics of culprit lesions in ACS include positive vessel remodeling (PR) and low-attenuation
plaques (LAP). These 2 features have been observed in the lesions that have already resulted in ACS, but their
prospective relation to ACS has not been previously described.
Methods In 1,059 patients who underwent CT angiography, atherosclerotic lesions were analyzed for the presence of 2
features: PR and LAP. The remodeling index, and plaque and LAP areas and volumes were calculated. The
plaque characteristics of lesions resulting in ACS during the follow-up of 27  10 months were evaluated.
Results Of the 45 patients showing plaques with both PR and LAP (2-feature positive plaques), ACS developed in 10
(22.2%), compared with 1 (3.7%) of the 27 patients with plaques displaying either feature (1-feature positive
plaques). In only 4 (0.5%) of the 820 patients with neither PR nor LAP (2-feature negative plaques) did ACS de-
velop. None of the 167 patients with normal angiograms had acute coronary events (p  0.001). ACS was inde-
pendently predicted by PR and/or LAP (hazard ratio: 22.8, 95% confidence interval: 6.9 to 75.2, p  0.001).
Among 2- or 1-feature positive segments, those resulting in ACS demonstrated significantly larger remodeling
index (126.7  3.9% vs. 113.4  1.6%, p  0.003), plaque volume (134.9  14.1 mm3 vs. 57.8  5.7 mm3, p
 0.001), LAP volume (20.4  3.4 mm3 vs. 1.1  1.4 mm3, p  0.001), and percent LAP/total plaque area
(21.4  3.7 mm2 vs. 7.7  1.5 mm2, p  0.001) compared with segments not resulting in ACS.
Conclusions The patients demonstrating positively remodeled coronary segments with low-attenuation plaques on CT angiography
were at a higher risk of ACS developing over time when compared with patients having lesions without these
characteristics. (J Am Coll Cardiol 2009;54:49–57) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.068d
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somputed tomographic (CT) angiography is a useful tool
or assessing not only coronary artery stenoses (1–8), but
lso plaque characteristics (9–18). The atherosclerotic
laques that are causally related to acute coronary syndromes
ACS) reveal a variable extent of luminal narrowing but are
lmost always associated with expansive or positive vessel
emodeling (PR) (16). The culprit lesions characteristically
rom the Departments of *Cardiology and †Radiology, Fujita Health University
chool of Medicine, Toyoake, Japan; ‡Division of Cardiology, University of Califor-
ia Irvine School of Medicine, Irvine, California; §Cardiovascular Pathology Insti-
ute, Gaithersburg, Maryland; and the Department of Cardiology, Takese Clinic,
akasaki, Japan. Drs. Ozaki and Narula contributed equally to this work. Paul
choenhagen, MD, served as Guest Editor for this article.o
Manuscript received August 14, 2008; revised manuscript received February 10,
009, accepted February 10, 2009.emonstrate low-attenuation plaques (LAP) (16). The non-
alcified plaques (NCP) with 30 HU density identified by
T angiography correlate closely with intravascular ultra-
ound (IVUS)-verified low attenuation in coronary athero-
clerotic plaques (15). Although these plaque charac-
See page 58
eristics on CT angiography have only been reported after
he occurrence of acute events, it is conceivable that such
haracteristics in the absence of ACS would indicate plaque
nstability (17,20). We, therefore, analyzed CT angio-
raphic findings in 1,000 subjects and classified athero-
clerotic plaques in10,000 coronary artery segments based
n the presence of 2 features: PR and LAP. We monitored
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development of acute coronary
events and correlated them with
qualitative and quantitative pres-
ence of plaque characteristics.
Methods
In all, 1,160 consecutive subjects
(835 men and 325 women) who
underwent coronary CT angiog-
raphy for suspected or known
coronary artery disease from
February 2003 to May 2006 were
included in this study. These pa-
ients were followed up for 12 to 50 months for the
evelopment of ACS. Of these, 101 patients were excluded
rom analyses because 64 patients underwent coronary artery
ypass surgery, 3 patients died of noncardiac causes, and 4
atients were hospitalized for heart failure in the first 12
onths; the follow-up was inadequate (12 months) in 22
atients, and the culprit lesions could not be identified in 8
CS patients. Hence, for the present study, all plaques were
nalyzed in 1,059 patients. The study end point was
escribed as the occurrence of ACS, based on the definition
et forth by the European Society of Cardiology and
merican College of Cardiology (21,22). ACS was defined
s ischemic discomfort presenting with elevation of tropo-
in level, and ischemic discomfort that was Canadian
ardiology Society class 3 or 4 without elevation of tropo-
in level. The culprit lesion in ACS was determined based
n invasive coronary angiography, echocardiography, and an
lectrocardiogram.
On CT images, coronary arteries were divided into 15
egments based on the recommendations of the American
eart Association (23). The segments treated previously
y percutaneous coronary intervention (PCI) or those
cheduled for PCI were excluded from the assessment.
herefore, all remaining 10,037 coronary artery segments
ith a diameter of 2 mm were evaluated for the
resence of plaques. All plaques were characterized for
he presence of vessel remodeling (positive, negative, or
one), plaque consistency (low or intermediate attenua-
ion, i.e., NCP 30 or 30 HU  NCP 150 HU,
espectively) and disposition of coronary calcification
spotty or large). The characteristics of the plaques
esulting in ACS were compared with those not resulting
n a subsequent acute event. The magnitude of the whole
laque as well as the low-attenuation plaque and the
xtent of vascular remodeling were calculated. The study
as approved by the Institutional Review Board and the
thics committees of Fujita Health University. The
ollow-up information was obtained from the hospital
hart review; the patients’ records are very complete
ecause all patients are almost always followed up at the
Abbreviations
andAcronyms
ACS  acute coronary
syndrome
CT  computed
tomography
IVUS  intravascular
ultrasound
LAP  low attenuation
plaque(s)
NCP  noncalcified plaque(s)
PR  positive vessel
remodelingame hospital. dT angiography, interpretation, and plaque character-
zation. The 64-slice CT (Aquilion 64, Toshiba Medical
ystems, Otawara, Japan) was employed with a collimation
f 64  0.5 mm, detector pitch of 9.8 to 11.2, pixel size of
.39 0.39 mm, rotation time of 350, 375, or 400 ms, tube
urrent of 400 or 450 mA, and voltage of 135 kV in 249
atients. For the contrast-enhanced scan, 60 ml of contrast
edia was injected at 4.0 ml/s followed by 20 ml at 2.0 ml/s.
n the remaining 911 patients, 16-slice CT (Aquilion 16,
oshiba Medical Systems) was used with a collimation of
6  0.5 mm, detector pitch of 3.2 to 3.6, pixel size of
.39  0.39 mm, rotation time of 400 ms, tube current
f 360 mA, and voltage of 135 kV. For the contrast-
nhanced scan, 60 ml of contrast media was injected at 3.0
l/s followed by 40 ml at 1.5 ml/s. The start of contrast-
nhanced scan was adapted to SureStart imaging (Toshiba
edical Systems) (24). All scans were performed during a
ingle breath-hold. Patients received a beta-blocker 1 h
efore the CT scan if the heart rate was 60 beats/min.
he raw data of the scans was reconstructed using algo-
ithms optimized for retrograde ECG-gated multislice spi-
al reconstruction. The reconstructed image data of CT was
ransferred to a computer workstation for post-processing
ZIO M900, Amin/ZIO, Tokyo, Japan). For plaque detec-
ion, both cross-sectional and curved multiplanar reforma-
ion images were analyzed. The reconstructed image data of
T was also transferred to Sure Plaque software (Toshiba
edical Systems) to measure the plaque area and volume.
ESSEL REMODELING. Coronary arterial remodeling was de-
ned as a change in the vessel diameter at the plaque site in
omparison to the reference segment set proximal to the
esion in a normal-appearing vessel segment (reference
iameter). Manual inspection, in both cross-section and
ongitudinal reconstruction, was used for defining the re-
odeling index (lesion diameter/reference diameter). The
emodeling index was reported as positive remodeling when
he diameter at the plaque site was at least 10% larger than
he reference segment.
LAQUE CONSISTENCY. We defined the plaque consistency
ased on our previously reported comparison of CT angiog-
aphy and IVUS data (15). In that study, the HU attenua-
ion of IVUS-verified lipid cores was 11  12 HU (range
15 to 33 HU), fibrous plaques 78  21 HU (range 32
o 130 HU), and calcified plaques 516  198 HU (range
21 to 1,134 HU); the density of the lumen was 258  43
U (range 174 to 384 HU). Based on the distribution of
U in comparison to the IVUS-verified lipid cores, we
roposed 30 HU as the cutoff point for the detection of lipid
ores with a sensitivity and specificity of 91% and 100%
15,16). The IVUS-verified fibrous plaques were defined as
0 to 150 HU. As such, all NCP in the present study were
lassified into 2 categories: (NCP 30 HU) and interme-
iate attenuation plaques (30 HU  NCP 150 HU).
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June 30, 2009:49–57 CT Characteristics of Plaques Developing ACSALCIFICATION. Plaque calcification was classified as spotty
r large. Spotty calcification was defined as 3 mm in size
25) on curved multiplanar reformation images and occu-
ied only 1 side on cross-sectional images. Large calcifica-
ion was defined as the calcification larger than spotty
alcification.
In all, 10,037 coronary artery segments were evaluated for
he presence of plaques in 1,059 patients. Each plaque in
very coronary artery segment was analyzed for the 2
eatures, namely, PR and LAP. All patients and all coronary
egments were then classified as 2-feature positive (PR and
AP) plaque, 1-feature positive (either PR or LAP) plaque,
-feature negative (absence of both PR and LAP) plaque, or
o plaques. All 2- and 1-feature positive plaques were
urther characterized for the extent of PR (remodeling
ndex), total plaque volume, LAP plaque volume, maximum
AP area in the cross-sectional images, and percent maxi-
um LAP area/plaque area. Plaque area and volume were
easured semiautomatically using Sure Plaque software
ased on CT density. All scans were evaluated by 1
nvestigator (S.M.). All 1- or 2-feature positive plaques were
eanalyzed by 2 investigators (S.M. and K.I.) together. They
sed automatic detection first, then corrected manually
herever needed, and agreed on the definition of outer
order in each segment. Both investigators also confirmed
he presence of LAP manually. The plaque characteristics of
esions resulting in ACS were compared with those not
esulting in ACS.
tatistical analyses. The proportion of event-free patients
as estimated by the Kaplan-Meier method and compared
etween plaque groups by use of the log-rank test. Categorical
ariables were expressed as percentages, and the Fisher exact
est (or Student t test for age) was used for comparisons
etween those with and without ACS. Those variables signif-
cant at p  0.05 or better were included in the multivariable
ox proportional hazards regression to evaluate for factors that
ere independently associated with the future development of
CS. Analysis of covariance (adjusted for age, hypertension,
yperlipidemia, and prior MI) was performed similarly to
ompare mean values of continuously measured plaque mea-
ures between those with and without ACS. Cutoff values for
eveloping ACS for each plaque characteristic were deter-
ined based on receiver-operator characteristic (ROC) curves.
he sensitivity, specificity, positive predictive value, and neg-
tive predictive value of various characteristics were also calcu-
ated. The chi-square test was used to compare the presence of
CS between those with and without spotty calcification in
egments with PR and LAP. All p values were 2-sided, and a
alue of p  0.05 was considered statistically significant. All
nalyses were performed with SPSS (SPSS Japan Inc., Tokyo,
apan).
esults
atient-based analyses. In all, 1,059 subjects (age 64 11
ears; 780 male, 279 female) undergoing CT angiography
*or established or suspected coronary artery disease were
ollowed up for at least 12 months (mean 27  10 months;
ange 12 to 50 months). Of these, 351 patients had
ypertension (33%), 337 hyperlipidemia (32%), and 175
ad diabetes mellitus (17%); 208 (20%) subjects were active
mokers, and 292 (28%) had a history of previous myocar-
ial infarction (MI) (Table 1). Of 1,059 patients, 367 had a
75% stenotic lesion in at least 1 coronary vessel.
Of the 1,059 subjects, 15 had ACS during the follow-up;
of 1,059 (0.8%) had the acute event within the first 12
onths. Follow-up data were available up to 24 months for
18 (68%) of the 1,059 subjects; 5 of these 718 (0.7%) had
CS during 12 to 24 months. During the follow-up of25
onths in 319 patients, ACS developed in 1 (0.3%). The
ssessment of CT angiography revealed that 45 patients had
-feature positive plaques (plaques with both PR and LAP),
7 had 1-feature positive plaque (either PR or LAP), and
20 had 2-feature negative plaques (neither PR nor LAP);
o plaques were detected in the remaining 167 subjects
Fig. 1). Of the 45 patients showing 2-feature positive
laques, 10 (22.2%) had ACS during follow-up, compared
ith 1 of the 27 patients with 1-feature positive plaques
3.7%; p  0.05). Conversely, only 4 (0.49%) of the 820
atients with 2-feature negative plaques (p  0.001) and
one of the 167 patients with normal arteries had an acute
vent. A case example is presented in Figure 2. Compari-
ons of clinical factors of all subjects in whom ACS
eveloped and did not develop are shown in Table 2;
ypertension (66.7% vs. 32.7%, p  0.008), hyperlipidemia
80.0% vs. 31.1%, p  0.001), previous MI (66.7% vs.
7.0%, p  0.002), and 2- or 1-feature positive plaques
73.3% vs. 5.8%, p  0.001) were significantly different.
rom multivariable Cox regression analysis of these 4
elected variables in 1,059 patients, the presence of 2- or
-feature positive plaques was the only significant indepen-
ent predictor of ACS (hazard ratio: 22.8, 95% confidence
nterval: 6.9 to 75.2, p  0.001) (Table 3). As such, there
as a significantly higher likelihood of ACS in patients with
- or 1-feature positive plaques compared with patients with
-feature negative plaques or no plaques (22.2% vs. 3.7% vs.
.49%, log-rank test p  0.001) (Fig. 3). Clinical charac-
eristics and risk factor profiles of 72 patients with 2- or
atient Characteristics
Table 1 Patient Characteristics
Variables n (%)
Age, yrs 64 11
Male 780 (74)
Hypertension 351 (33)
Hyperlipidemia 337 (32)
Diabetes mellitus 175 (17)
Obesity 173 (16)
Smoking 208 (20)
Previous myocardial infarction 292 (28)
1VD/2VD/3VD including LMCA* 250/96/21 (24/9/2)Lesions with 75% stenosis, including percutaneous coronary intervention lesions.
LMCA  left main coronary artery; VD  vessel disease.
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CT Characteristics of Plaques Developing ACS June 30, 2009:49–57-feature positive plaques are shown in Table 4. There was
o statistically significant difference in age, sex, presence of
isk factors, previous MI or PCI, the coronary artery
nvolved, and statin use after CT angiography, between
atients having and not having ACS.
egment-based analyses. Of the 10,688 segments (1,059
ubjects) analyzed, 651 segments were excluded because
hey either contained target lesions for scheduled PCI or
hey were previously subjected to PCI (Fig. 4). Therefore,
0,037 segments were analyzed, wherein unstable plaques
ere suspected in 74 segments: 45 segments (from 45
Figure 1 Acute Coronary Events in Patients on the Basis of Pla
Of the 45 patients showing 2-feature positive plaques, 10 (22.2%) developed acut
plaques had ACS (3.7%). Only 4 (0.5%) of the 820 patients with 2-feature negative
oped ACS. LAP  low-attenuation plaque; PR  positive vessel remodeling.
Figure 2 Example of a Patient With ACS 6 Months After CT An
(A) Curved multiplanar reformation images of left anterior descending artery (LAD)
low-attenuation plaque, and spotty calcification were detected in LAD #6 on coron
curred 6 months after CT angiography. LAD #6 was determined as the culprit lesio
sion proximal to the first septal branch, both in CT angiography before the event a
tion laboratory for percutaneous coronary intervention. LCA  left coronary artery.atients) contained 2-feature positive plaques and 29 seg-
ents (from 27 patients) contained 1-feature positive
laques. In 2,853 of 10,037 segments, 2-feature negative
laques were observed, and no plaques were seen in the
emaining 7,110 coronary artery segments. Of the 74
laques classified as either 2- or 1-feature positive, 6
esulted in ACS in the first 12 months after CT examina-
ion, and an additional 5 resulted in ACS in 13 to 24
onths. In 11 of these 2- or 1-feature positive plaques in
atients who subsequently had ACS, the culprit lesion
howed 50% stenosis in 7 and 25% stenosis in 4 lesions.
Characteristics
nary syndrome (ACS), whereas 1 of the 27 patients with 1-feature positive
ns had an acute event, and none of the 167 patients with normal arteries devel-
aphy
ircumflex artery (LCX), and right coronary artery (RCA). (B) Positive remodeling,
mputed tomography (CT) angiography. (C) Acute coronary syndrome (ACS) oc-
ed on invasive coronary angiogram findings. Please note the location of the le-
onary angiogram after the event when the patient was brought to the catheteriza-que
e coro
lesiogiogr
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June 30, 2009:49–57 CT Characteristics of Plaques Developing ACSThe metrics of either 2- or 1-feature positive plaques that
ed to ACS were different from those of the plaques that did
ot lead to ACS (Table 5). The remodeling index (126.7 
.9% vs. 113.4  1.6%, p  0.003), total plaque volume
134 .9  14 .1 mm 3 vs . 57 .8  5 .6 mm 3 ,
 0.001), maximum LAP area (3.2  0.5 mm2 vs. 0.5 
.2 mm2, p  0.001), and maximum LAP area/plaque area
n cross-sectional images (21.4  3.7% vs. 7.7  1.5%, p 
.001) were significantly larger in plaques resulting in ACS
ompared with those that did not. Furthermore, the 2- or
-feature positive plaques that resulted in ACS within 12
onths were compared with plaques that did not result in
CS within 12 months (Table 5). The CT characteristics of
he plaques resulting in ACS earlier were more striking.
here were significant differences in the remodeling index
131.1  5.1% vs. 120.8  5.9% vs. 113.4  51.6%, p 
.005), total plaque volume (166.5  17.8 mm3 vs. 92.8 
0.4 mm3 vs. 58.1  5.5 mm3, p  0.001), maximum LAP
rea (4.7  0.5 mm2 vs. 1.2  0.6 mm2 vs. 0.5  0.2 mm2,
 0.001), and maximum LAP area/plaque area in
ross-sectional images (31.5  4.5% vs. 8.1  5.2% vs. 7.8
1.4%, p  0.001) between those associated with subse-
uent ACS in 12 months, ACS in 13 to 24 months, and
hose not associated with ACS in 24 months, respectively.
utoff values for developing ACS in each plaque character-
stics were determined based on ROC curve analyses (Fig.
). The sensitivity, specificity, positive predictive value, and
egative predictive value of various characteristics indepen-
ently are provided in the Figure 5.
ole of spotty calcification. Our previous study of plaque
haracterization in patients presenting after ACS had dem-
nstrated a modest association with spotty calcification (16).
ultivariate Cox Regression Analysis for Development of Acute Co
Table 3 Multivariate Cox Regression Analysis for Development
Variables ß SE
Hypertension 0.687 0.575
Hyperlipidemia 1.293 0.679
Previous myocardial infarction 0.806 0.575
omparison of Clinical Profile of Allubjects Wh Did and Did Not Develop ACS
Table 2 Comparison of Clinical Profile of AllSubjects Who Did and Did Not Develop ACS
ACS
n  15 (1.4%)
No ACS
n  1,044 (98.6%) p Value
Age, yrs 67.7 8.3 63.7 10.5 0.14
Male 13 (87.7%) 767 (73.5%) 0.22
Hypertension 10 (66.7%) 341 (32.7%) 0.008
Hyperlipidemia 12 (80.0%) 325 (31.1%) 0.001
Diabetes mellitus 4 (26.7%) 171 (16.4%) 0.32
Smoking* 5 (33.3%) 203 (19.4%) 0.21
Obesity (BMI 25 kg/m2) 2 (13.3%) 171 (16.4%) 0.74
Previous MI 10 (66.7%) 282 (27.0%) 0.002
2- or 1-feature positive plaques 11 (73.3%) 61 (5.8%) 0.001
Current versus former and never.
ACS  acute coronary syndrome; BMI  body mass index; MI  myocardial infarction.resence of spotty calcification in positively remodeled LAP
hat resulted in ACS (27%) was twofold more frequent than
he vulnerable plaques that did not lead to ACS (13%);
owever, this difference was not statistically significant (p 
.31) owing to the small number of plaques associated with
CS.
iscussion
he present study. Our study was designed to evaluate the
ole of CT plaque characterization for predicting acute
oronary events in 1,000 subjects with established or
uspected coronary artery disease who were followed up for
n average of 27 months. On the basis of the previous
nformation (16) about the plaques associated with culprit
esions in ACS, plaque vulnerability was assessed by the
resence of 2 features: positive vessel remodeling at the
esion site, and LAP. Of 45 patients carrying a 2-feature
ositive plaque (PR and LAP), 10 had acute coronary events
ithin the next 2 years, offering a 22% risk. In patients
ith 2-feature negative plaques (showing neither PR nor
AP), 0.5% patients had acute events. In addition,
-feature positive plaques had a higher likelihood of result-
ng in acute events compared with 2-feature negative
esions. It seems logical to propose that 2-feature positive
y Syndrome
ute Coronary Syndrome
p Value Hazard Ratio 95% Confidence Interval
0.233 1.99 0.64–6.14
0.057 3.65 0.96–13.79
0.154 2.24 0.74–6.79
Figure 3 Kaplan-Meier Curve for Development of
ACS on the Basis of Plaque Characteristics
Patient stratification according to the presence of 2- and 1-feature positive,
and 2-feature negative plaques/no plaques. The y-axis represents cumulative
event-free rate (log-rank test, p  0.001). ACS  acute coronary syndrome.ronar
of Ac
2- or 1-feature positive plaques 3.126 0.609 0.001 22.79 6.91–75.17
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CT Characteristics of Plaques Developing ACS June 30, 2009:49–57esions can be considered potentially vulnerable, and
-feature negative plaques potentially stable.
Our data suggest that once a patient is identified to be at
igh risk of having an adverse cardiac event on the basis of
raditional clinical, biochemical, and biomarker risk profiles,
maging may help identify those at greater risk of acute
oronary events. Of interest, only 2-feature positive plaques
esulted in acute events that were significantly positively
emodeled, and had larger plaque volumes and LAP vol-
mes. Furthermore, the plaque volumes and LAP volumes
ere substantially greater in the plaques that led to acute
vents within the first year of follow-up. All acute events in
Figure 4 Plaque Characteristics and Incidence of ACS by Segm
2- and 1-feature positive plaques were identified in 74 segments, 2-feature negati
7,110 segments. Of 74 segments with 2- and 1-feature positive plaques, 6 (8.1%
tomography examination, and an additional 5 (17.2%) of 29 plaques resulted in A
neous coronary intervention; PR  positive vessel remodeling.
omparison of Clinical Profile of Subjects With 2- or-Feature Positive Pl ques in Whom ACS Did andid Not Develop
Table 4
Comparison of Clinical Profile of Subjects With 2- or
1-Feature Positive Plaques in Whom ACS Did and
Did Not Develop
ACS
n  11 (15%)
No ACS
n  61 (85%) p Value
Age, yrs 66.3 8.2 65.8 9.5 0.84
Male 11 (100%) 51 (83.6%) 0.34
Hypertension 8 (62.5%) 31 (50.8%) 0.21
Hyperlipidemia 9 (75.0%) 36 (59.0%) 0.19
Diabetes mellitus 2 (25.0%) 18 (29.5%) 0.72
Smoking* 4 (25.0%) 19 (31.1%) 0.74
Obesity (BMI 25 kg/m2) 1 (12.5%) 8 (13.1%) 0.99
Previous MI 8 (72.7%) 32 (52.5%) 0.33
Previous PCI 8 (72.7%) 32 (52.5%) 0.33
Statin use after CTA 6 (62.5%) 41 (67.2%) 0.50
Current versus former and never.
CTA  computed tomography angiography; PCI  percutaneous coronary intervention; other
bbreviations as in Table 2.- or 1-feature positive plaques occurred within the first 2
ears of follow-up. Although the number of subjects with 3-
nd 4-year follow-up is significantly smaller, it seems logical
hat the natural history of the plaques after the CT
xamination (possibly because of pharmacological interven-
ion and life-style modification taking effect) is altered
ignificantly, and the initial scan results may not remain
ecessarily discriminatory thereafter.
T characteristics confirm histopathological information.
laque rupture is a substrate for ACS in up to 75% patients
resenting with ACS, and pathological characteristics of
laques vulnerable to rupture are well established (19,20).
hese plaques are typically voluminous, contain large ne-
rotic cores, and induce expansive remodeling of the vascu-
ar segment; these plaques are covered by thin and inflamed
brous caps. The larger the plaque extent and necrotic core
ize, the higher is the likelihood of vulnerability of the
laque to rupture (19,26).
Whereas 80% of ruptured plaques occupy at least one-
alf of the vessel area in a cross section, 40% of ruptured
laques involve more than three-fourths of the cross-
ectional vascular area. The plaques that are vulnerable to
upture also demonstrate large plaque areas, but the dimen-
ions are somewhat smaller than the ruptured plaques,
uggesting that the larger the plaque size, the more vulner-
ble is the lesion. The CT characteristics as observed in this
tudy also reflect similar findings. Of the 74 plaques that
ere considered to be unstable, the plaque size was signif-
cantly larger in plaques that caused the events compared
ased Analysis
ues were observed in 2,853 of 10,037 segments, and no plaques were seen in
ted in acute coronary syndrome (ACS) in the first 12 months after computed
3 to 24 months. F/U  follow-up; LAP  low-attenuation plaque; PCI  percuta-ent-B
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June 30, 2009:49–57 CT Characteristics of Plaques Developing ACSith plaques that did not lead to acute events in follow-up.
he plaques were even larger in patients who had ACS in
he first year of follow-up. Although plaque volume is often
normous in unstable plaques, plaque burden may not
ecessarily compromise the lumen diameter significantly,
nd sparing of the lumen occurs because of a positive or
utward vessel remodeling (27,28). Therefore, angiographic
ncroachment of the lumen has often been reported as
50% in ACS (29). Conversely, stable plaques or ACS
ssociated with plaque erosion do not show expansive
emodeling (30,31). In the present study, the vessel seg-
ents containing the ACS culprit lesions demonstrated
reater remodeling compared with vulnerable plaques that
ere not associated with subsequent ACS in the follow-up
eriod.
Not only are plaques that are vulnerable to rupture larger
n volume, these plaques also harbor large necrotic cores.
he necrotic core in a vulnerable plaque often occupies 25%
f the plaque area (32); they are 2 to 22 mm long (median
mm), and in up to 75% plaques are spread over 120° or
ore of vascular circumference (20,26). The LAP areas,
hich are expected to represent necrotic cores, were signif-
cantly larger in the plaques associated with ACS compared
ith the unstable plaques that did not. Similarly, LAP areas
ere significantly larger in the plaques that resulted in ACS
n the first year after CT examination. In fact, 21% of the
laque area demonstrated low attenuation and confirmed
he morphologic observations described in autopsy data
32). The CT information from the present study is also
imilar to the descriptions available from an IVUS study
33), wherein the plaques leading to an acute coronary event
ubsequently exhibited a large eccentric plaque containing
omparison of CT Characteristics of 2- or 1-Feature Positive Plaqu
Table 5 Comparison of CT Characteristics of 2- or 1-Feature Po
2-Feature Positive Plaques
ACS
(n  11)
No ACS
(n  63) Va
Remodeling index (%) 0.
Mean  SE 126.7 3.9 113.4 1.6
95% confidence interval (118.9 to 134.5) (110.2 to 116.6)
Total plaque volume (mm3) 0.
Mean SE 134.9 14.1 57.8 5.7
95% confidence interval (106.8 to 162.9) (46.3 to 69.2)
LAP volume (mm3) 0.
Mean SE 20.4 3.4 1.1 1.4
95% confidence interval (13.58 to 27.21) (1.7 to 3.9)
Maximum LAP area (mm2) 0.
Mean  SE 3.2 0.5 0.5 0.2
95% confidence interval (2.3 to 4.1) (0.2 to 0.9)
Maximum LAP area/plaque area (%) 0.
Mean SE 21.4 3.7 7.7 1.5
95% confidence interval (14.1 to 28.7) (4.7 to 10.6)
nalysis of covariance adjusted for age, hypertension, hyperlipidemia, and prior MI. p values repre
LAP  low-attenuation plaque; NCP  noncalcified plaque; other abbreviations as in Table 2.n echolucent zone by IVUS. rlinical implications. Traditionally, the risk of acute cor-
nary events is calculated on the basis of clinical and
iochemical characteristics (34,35). Such risk scores have
een refined by the use of circulating biomarkers (36).
symptomatic patients who are at a high-intermediate or
igh risk of having ACS, namely, 10% over 10 years, are
ubjected to intense global risk factor reduction by behav-
oral modification and pharmacologic intervention. It has
een hypothesized that noninvasive imaging modalities
uch as CT angiography or positron emission tomography
ay further stratify high-risk patients to a very high-risk
roup (34). Localization of plaques showing both PR and
AP (2-feature positive plaque) may portend a higher
ikelihood of the future development of ACS for the next 2
ears. Whether these findings extend to the larger group of
symptomatic intermediate- and/or high-risk patients
ould require a larger multicenter study.
Although CT angiography may be significantly more
redictive of coronary disease compared with the Framing-
am risk score (37), and a positive scan may identify
ignificantly increased risk for all cause death (38), current
ppropriateness guidelines do not recommend screening
ith CT angiography (39). It is partly because of radiation
ose, use of contrast media, cost effectiveness, and a lack of
vidence. All patients with subsequent ACS in the present
tudy had culprit lesions that were 75% stenotic at the
ime of CT angiography. Such subjects who are likely to be
symptomatic may not be candidates for CT angiography by
he American Heart Association/American College of Car-
iology criteria (Class III, Level of Evidence: C). Recent
dvances in CT technology employing a larger number of
lices (8,40), prospective ECG-gating scan (41), or dual-
ource CT (42) offer a promise of substantial reduction in
at Did or Did Not Develop ACS
e Plaques That Did or Did Not Develop ACS
1-Feature Positive Plaques
ACS 0–12 Months
(n  11)
ACS 13–24 Months
(n  5)
No ACS in 24 Months
(n  24)
p
Value
0.005
131.2 5.1 120.8 5.9 113.4 1.6
(120.9 to 141.4) (109.1 to 132.6) (110.3 to 116.6)
0.001
166.5 17.8 92.8 20.4 58.1 5.5
(131.1 to 201.9) (52.1 to 133.6) (47.1 to 69.1)
0.001
30.5 4.1 6.9 4.8 1.2 1.3
(22.3 to 38.8) (2.6 to 16.4) (1.3 to 3.8)
0.001
4.7 0.5 1.2 0.6 0.5 0.2
(3.6 to 5.7) (6.6 to 2.4) (0.2 to 0.9)
0.001
31.5 4.5 8.1 5.2 7.8 1.4
(22.5 to 40.4) (2.2 to 18.4) (5.0 to 10.5)
mparison across groups.es Th
sitiv
p
lue
003
001
001
001
001adiation burden, which may facilitate application of CT
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CT Characteristics of Plaques Developing ACS June 30, 2009:49–57ngiography for screening purposes. The guidelines recom-
end continuous research in cardiac CT imaging to deter-
ine the potential of noncatheter-based modalities to de-
ect, characterize, and measure atherosclerotic plaque
urden, and monitor change in plaque burden over time or
n response to therapeutic intervention (Class I, Level of
vidence: C).
tudy limitations. The foremost limitation of the study is
he proposal of the cutoff value of 30 HU for the LAP.
his value was defined on the basis of our IVUS-CT
ngiography comparison study (15). However, many centers
se50 HU as the cutoff level for the soft plaques. The CT
Figure 5 ROC Curve and Cutoff Values for Various
Plaque Characteristics for Developing ACS
Receiver-operator characteristic (ROC) curves for (A) remodeling index, (B)
total plaque volume, (C) low-attenuation plaque (LAP) volume, and (D) maxi-
mum LAP area/plaque area. (E) Cutoff values of various plaque characteristics
and their diagnostic accuracy in subsequent acute coronary syndrome (ACS).
AUC  area under the curve; NPV  negative predictive value; PPV  positive
predictive value; Sens  sensitivity; Spec  specificity.laque density is likely to be affected by various factors suchs the lumen density of contrast (43,44) and the tube
oltage. We used a tube voltage of 135 kV, unlike the most
ractices in which CT studies are performed at 120 kV or
ome in which dual energy scanning is performed (45–47).
s such, a better definition of LAP will need to be
stablished. Second, although this study includes a large
ohort of patients, the number of clinical events is small and
ollow-up limited to2 years. For clarification of the short-
nd long-term prognostic role of CT angiography, and for
ider applicability in the high-risk asymptomatic patients, a
arger number of events from longer-term follow-up and/or
tudy of a greater number of subjects would be required.
onetheless, these data form an important foundation for
eveloping imaging-based prevention studies. It is likely
hat imaging biomarkers may be able to help improve risk
tratification based on clinical and biochemical profiles.
onclusions
he present CT angiography study demonstrates that cor-
nary plaques that are likely to result in subsequent ACS
uring follow-up are often voluminous and contain large
reas of low attenuation. These coronary plaques are asso-
iated with positive vascular remodeling. Although larger
nd longer follow-up studies will be necessary for establish-
ng the role of CT angiography in high-risk asymptomatic
ubjects, these CT characteristics confirm previously re-
orted pathologic features of unstable plaques.
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